RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
Adrian Sanz-Moreno; Sonia Palomeras, PhD; Kim Pedersen; Beatriz Morancho, PhD; Tomas Pascual, MD PhD; Patricia Galván; Sandra Benítez; Jorge Gomez-Miragaya; Marina Ciscar; Maria Jimenez; Sonia Pernas, MD PhD; Anna Petit, MD PhD; Maria Teresa Soler-Monsó, MD PhD; Gemma Viñas, MD PhD; Mansour Alsaleem; Emad A Rakha, MD PhD; Andrew R Green, MD PhD; Patricia G Santamaria, PhD; Celine Mulder, PhD; Simone Lemeer, PhD; Joaquin Arribas, PhD; Aleix Prat, MD PhD; Teresa Puig, PhD; Eva Gonzalez Suarez, PhD
Manuscrito
Breast Cancer Research
2021
PAMELA samples
